Barr recalls ADHD drugs due to risk of excess dose

08/17/2009 | Los Angeles Times (tiered subscription model)

Barr Laboratories has issued a recall of ADHD drugs Dextroamphetamine Saccharate, Amphetamine Aspartate and Amphetamine Sulfate because some pills were found to exceed weight specifications. Patients on the pills could get an excess dose, causing arrhythmia, stomach upset, elevated blood pressure, insomnia, diarrhea or constipation, and/or symptoms such as agitation, tics, euphoria or mania. The lot number of the recall is 311756.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD